Kuchyne na miru

EY Releases M&A Report for 2018

Jan 08, 2019
By Pharmaceutical Executive Editors

EY launched its M&A Firepower report, showing that life sciences mergers and acquisitions (M&A) activity in 2018 totaled $198 billion USD. According to the report, life sciences companies focused on building therapeutic scale and optimizing their portfolios, and the 2018 market conditions—especially high valuations for target acquisitions—drove dealmaking away from megamergers toward bolt-on acquisitions and divestitures.

Additionally, the uncertain return on investment and the rapid pace of technology change mean life sciences companies will likely prioritize digital alliances in favor of M&A in 2019.

Key findings highlighted in this year’s M&A Firepower report include:

  • Total M&A deal value driven by bolt-ons and divestitures, not megamergers
  • Firepower remains robust but is not being deployed
  • Focused companies outperform less focused counterparts
  • Market fragmentation likely to drive additional deals

The report identifies a number of key industry trends likely to drive M&A in 2019 and beyond:

  • Continued emphasis on portfolio optimization
  • Divestitures will increasingly be used to unlock value
  • Digital alliances should be a priority too


Read the full report .




вывоз мусора
lorem ipsum